Monday, February 20, 2023 1:16:04 PM
Facts as documented events:
1. SEC Reaudit of 3 years on Nov 15, 2013, 2 weeks before 10-K and growth funding to follow 1-yr anniversary of DC acquisition.
2. Asher lawsuit because they couldn’t convert.
3. Settlement on DBMM’s terms because they were precluded from “taking over” because of a Federal Consent Decree signed by Asher and Curt Kramer signed 2 days before Takeover Motion.
4. Of course they wanted the Company for an in place UK company. They were unable to trade without sanctions in US. Very naive to think they “wanted their money.” Laughable to settle for far,far less.
More nonsense
Recent DBMM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 09:32:32 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/29/2023 09:31:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/17/2023 09:15:45 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM